No7 Stay Perfect Foundation Sunscreen SPF 15

Manufacturer
Boots Retail USA Inc | The Boots Company PLC | BCM Cosmetique SAS
Effective date
2010-06-04
Label type
HUMAN OTC DRUG LABEL
Version
3
Source
full-release
Hydrated at
2026-05-31 22:24:41

Label at a glance#

ProductNo7 Stay Perfect Foundation Sunscreen SPF 15 05
Active ingredientOCTINOXATE, TITANIUM DIOXIDE
Label structure16 sections

Storage and handling

Other information Do not store above 30 o C or 86 o F

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Active Ingredients                         Purpose

Octinoxate 5%                               Sunscreens

Titanium Dioxide 1.6%

OTC - PURPOSE SECTION

Uses

  • Provides moderate protection against adverse effects of the sun
  • Higher SPF gives more protection

WARNINGS AND PRECAUTIONS SECTION

Warnings

For external use only

When using this product

Keep out of eyes.  Rinse with water to remove.

OTC - ASK DOCTOR SECTION

Stop use and ask a doctor if rash or irritation develops and lasts

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

If swallowed get medical help.

INDICATIONS & USAGE SECTION

Directions

  • Use as a normal foundation
  • Apply evenly at least 15 minutes before sun exposure
  • Reapply as needed
  • Not intended for children under the age of 12
  • Not intended for protection while sunbathing

STORAGE AND HANDLING SECTION

Other information

Do not store above 30oC or 86oF

INACTIVE INGREDIENT SECTION

Inactive ingredients

Aqua (Water), Cyclopentasiloxane, Talc, Mica, Ethylhexyl stearate, Cyclohexasiloxane, Dimethicone, Silica, Butylene glycol, Cetyl PEG/PPG-10/1 Dimethicone, Disteardimonium hectorite, Hexyl laurate, Polyglyceryl-4 isostearate, Dimethicone copolyol, Magnesium sulfate, Phenoxyethanol, Propylene carbonate, Methylparaben, Sodium ascorbyl phosphate, Sodium PCA, Aluminum stearate, Alumina, Tocopheryl acetate, Propylene glycol, Glycerin, Triethoxycaprylylsilane, Sodium lauroyl lactylate, Isopropyl palmitate, Butylparaben, Ethylparaben, Lecithin, Tetrasodium EDTA, Propylparaben, Isobutylparaben, Ceramide 3, BHT, Ceramide 6 II, Cholesterol, Phytosphingosine, Morus alba leaf extract, Carbomer, Xanthan gum, Ceramide 1, [+/1 (May contain) CI 77891 (Titanium dioxide), CI 77492 (Iron oxides), CI 77491 (Iron oxides), CI 77499 (Iron oxides).

OTC - QUESTIONS SECTION

Questions? 1-866-75-BOOTS

DESCRIPTION SECTION

Staying power...

Discover picture-perfect skin from morning till night, with this stay perfect moisturising foundation.  Soft, silky and flattering in any light, it's rub resistant and won't let you down.  Fragrance free and easy to blend without blocking your pores.

Ready to face the day...

Shake before use.  Dot onto your face and blend smoothly and evenly with your fingers or a sponge, working downwards and outwards from the centre of your face.

Non-pore blocking.

INFORMATION FOR PATIENTS SECTION

www.boots.com

Mfd in France for BBI NG2 3AA. UK

Dist in the USA by Boots Retail USA Inc Stamford CT 06901

OTC - ACTIVE INGREDIENT SECTION


Bottle label

Active Ingredients:

Octinoxate 5%

Titanium Dioxide 1.6%

DESCRIPTION SECTION

Discover picture-perfect skin from morning till night, with this stay perfect moisturising foundation.  Soft, silky and flattering in any light, its rub resistant and won't let you down.

Shake well before use.  Blend on smoothly and evenly with your fingers or a sponge.

Non-pore blocking.

INFORMATION FOR PATIENTS SECTION

www.boots.com

Mfd in France for BBI Ltd NG2 3AA. UK

Dist in the USA by Boots Retail USA Inc. Stamford CT 06901

USA: Questions? 1-866-75-BOOTS

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Carton label

No7 Stay Perfect

Perfection Continue

Foundation

Fond de Teint

For a long-lasting flawless finish

Sunscreen SPF 15

Hypo-allergenic

Boots

30ml e 1 US Fl. Oz

Stay Perfect Fdn carton.jpgStay Perfect Fdn cartonStay Perfect Fdn carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Stay Perfect

Foundation

Sunscreen SPF 15

Hypo-allergenic

Boots

30ml e 1 US Fl. Oz

Stay Perfect Fdn bottle labels.jpgStay Perfect Fdn bottle labelsStay Perfect Fdn bottle labels

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
68472-088-012019-10-21C16284748780-1956f9ecf-de6f-621f-e053-dbdaa90a74adCarton and bottle labelling

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
68472-088-01No7 Stay Perfect Foundation Sunscreen SPF 150530 mL in 1 BOTTLE, GLASSEMULSION303
68472-088-01No7 Stay Perfect Foundation Sunscreen SPF 15051 in 1 CARTONEMULSION13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
68472-088NO7 STAY PERFECT FOUNDATION SUNSCREEN SPF 15 05 (OCTINOXATE AND TITANIUM DIOXIDE) EMULSION [BOOTS RETAIL USA INC]3Legacy NDC, 2 package rows20100604_f6747fcd-699c-49d3-9f8d-953e7e0fd97e.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
OCTINOXATEACTIVE INGREDIENT4Y5P7MUD513
TITANIUM DIOXIDEACTIVE INGREDIENT15FIX9V2JP3
OCTINOXATEACTIVE MOIETY4Y5P7MUD513
TITANIUM DIOXIDEACTIVE MOIETY15FIX9V2JP3
.ALPHA.-TOCOPHEROL ACETATE, DL-INACTIVE INGREDIENTWR1WPI7EW83
ALUMINUM OXIDEINACTIVE INGREDIENTLMI26O69333
ALUMINUM STEARATEINACTIVE INGREDIENTU6XF9NP8HM3
ASIAN GINSENGINACTIVE INGREDIENTCUQ3A77YXI3
BUTYLATED HYDROXYTOLUENEINACTIVE INGREDIENT1P9D0Z171K3
BUTYLENE GLYCOLINACTIVE INGREDIENT3XUS85K0RA3
BUTYLPARABENINACTIVE INGREDIENT3QPI1U3FV83
CARBOMER HOMOPOLYMER TYPE CINACTIVE INGREDIENT4Q93RCW27E3
CHOLESTEROLINACTIVE INGREDIENT97C5T2UQ7J3
CYCLOMETHICONE 5INACTIVE INGREDIENT0THT5PCI0R3
CYCLOMETHICONE 6INACTIVE INGREDIENTXHK3U310BA3
DIMETHICONEINACTIVE INGREDIENT92RU3N3Y1O3
EDETATE SODIUMINACTIVE INGREDIENTMP1J8420LU3
ETHYLPARABENINACTIVE INGREDIENT14255EXE393
FERRIC OXIDE REDINACTIVE INGREDIENT1K09F3G6753
FERRIC OXIDE YELLOWINACTIVE INGREDIENTEX438O2MRT3
FERROSOFERRIC OXIDEINACTIVE INGREDIENTXM0M87F3573
GLYCERININACTIVE INGREDIENTPDC6A3C0OX3
HEXYL LAURATEINACTIVE INGREDIENT4CG9F9W01Q3
ISOBUTYLPARABENINACTIVE INGREDIENT0QQJ25X58G3
ISOPROPYL PALMITATEINACTIVE INGREDIENT8CRQ2TH63M3
LECITHIN, SOYBEANINACTIVE INGREDIENT1DI56QDM623
MAGNESIUM SULFATEINACTIVE INGREDIENTDE08037SAB3
METHYLPARABENINACTIVE INGREDIENTA2I8C7HI9T3
OCTYLTRIETHOXYSILANEINACTIVE INGREDIENTLDC331P08E3
PHENOXYETHANOLINACTIVE INGREDIENTHIE492ZZ3T3
POLYGLYCERYL-4 ISOSTEARATEINACTIVE INGREDIENT820DPX33S73
PROPYLENE CARBONATEINACTIVE INGREDIENT8D08K3S51E3
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V33
PROPYLPARABENINACTIVE INGREDIENTZ8IX2SC1OH3
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU43
SODIUM ASCORBYL PHOSPHATEINACTIVE INGREDIENT836SJG51DR3
SODIUM PYRROLIDONE CARBOXYLATEINACTIVE INGREDIENT469OTG57A23
TALCINACTIVE INGREDIENT7SEV7J4R1U3
WATERINACTIVE INGREDIENT059QF0KO0R3
WHITE MULBERRYINACTIVE INGREDIENTMN25R0HH5A3
XANTHAN GUMINACTIVE INGREDIENTTTV12P4NEE3

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 2 · 41 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
68472-08868472-088-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 39 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 10 · 592 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KGEL / TOPICAL8 mgExact identifier — unii candidate
32 equally ranked IID candidates
FERRIC OXIDE REDFERRIC OXIDE RED1K09F3G675TABLET, ORALLY DISINTEGRATING / ORAL2 mgExact identifier — unii candidate
21 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXPASTE / ORAL3822 mgExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXINJECTION, SOLUTION / INTRAVENOUS15 %w/vExact identifier — unii candidate
75 equally ranked IID candidates
MAGNESIUM SULFATEMAGNESIUM SULFATEDE08037SABTABLET, FILM COATED / ORAL14 mgExact identifier — unii candidate
6 equally ranked IID candidates
MAGNESIUM SULFATEMAGNESIUM SULFATEDE08037SABTABLET, COATED / ORALNAExact identifier — unii candidate
6 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSYSTEM / TOPICAL18144 mgExact identifier — unii candidate
75 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET, FOR SUSPENSION / ORAL24 mgExact identifier — unii candidate
35 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SPRAY, METERED / NASAL240 mgExact identifier — unii candidate
81 equally ranked IID candidates
CARBOMER HOMOPOLYMER TYPE CCARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED)4Q93RCW27ECREAM / TOPICAL103 mgExact identifier — unii candidate
9 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3FILM, EXTENDED RELEASE / TRANSDERMAL58.13 mgExact identifier — unii candidate
81 equally ranked IID candidates
XANTHAN GUMXANTHAN GUMTTV12P4NEETABLET, CHEWABLE, EXTENDED RELEASE / ORAL6 mgExact identifier — unii candidate
29 equally ranked IID candidates
XANTHAN GUMXANTHAN GUMTTV12P4NEESOLUTION / ORAL84 mgExact identifier — unii candidate
29 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TINJECTION / INFILTRATION80 mgExact identifier — unii candidate
79 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3TABLET, COATED / ORAL16 mgExact identifier — unii candidate
81 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TPOWDER, FOR SUSPENSION / ORAL75 mgExact identifier — unii candidate
79 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4LOZENGE / ORAL120 mgExact identifier — unii candidate
49 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXTABLET, EXTENDED RELEASE / ORAL7 mgExact identifier — unii candidate
75 equally ranked IID candidates
ETHYLPARABENETHYLPARABEN14255EXE39POWDER, FOR SOLUTION / ORAL13 mgExact identifier — unii candidate
4 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4TABLET, FOR SUSPENSION / ORAL220 mgExact identifier — unii candidate
49 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3INJECTION / SUBCUTANEOUS1.4 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TTABLET, COATED / ORAL0.8 mgExact identifier — unii candidate
79 equally ranked IID candidates
FERRIC OXIDE YELLOWFERRIC OXIDE YELLOWEX438O2MRTCAPSULE / ORAL14 mgExact identifier — unii candidate
20 equally ranked IID candidates
FERRIC OXIDE REDFERRIC OXIDE RED1K09F3G675TABLET / BUCCAL0.4 mgExact identifier — unii candidate
21 equally ranked IID candidates
BUTYLPARABENBUTYLPARABEN3QPI1U3FV8TABLET / ORALNAExact identifier — unii candidate
15 equally ranked IID candidates
TALCTALC7SEV7J4R1UGRANULE / ORAL322 mgExact identifier — unii candidate
35 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOLUTION/ DROPS / AURICULAR (OTIC)25 mgExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXAEROSOL / TOPICAL3 %w/wExact identifier — unii candidate
75 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SUSPENSION, EXTENDED RELEASE / ORAL1000 mgExact identifier — unii candidate
81 equally ranked IID candidates
BUTYLATED HYDROXYTOLUENEBUTYLATED HYDROXYTOLUENE1P9D0Z171KINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS0.02 mgExact identifier — unii candidate
32 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3GEL / TOPICAL4522 mgExact identifier — unii candidate
81 equally ranked IID candidates
FERRIC OXIDE REDFERRIC OXIDE RED1K09F3G675SUSPENSION, EXTENDED RELEASE / ORAL2.7 mgExact identifier — unii candidate
21 equally ranked IID candidates
FERRIC OXIDE REDFERRIC OXIDE RED1K09F3G675CREAM / TOPICALNAExact identifier — unii candidate
21 equally ranked IID candidates
XANTHAN GUMXANTHAN GUMTTV12P4NEESUSPENSION / RECTAL452 mgExact identifier — unii candidate
29 equally ranked IID candidates
FERROSOFERRIC OXIDEFERROSOFERRIC OXIDEXM0M87F357TABLET, FILM COATED / ORAL0.2 mgExact identifier — unii candidate
10 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL69 mgExact identifier — unii candidate
49 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TSOLUTION / OPHTHALMIC0.05 %w/wExact identifier — unii candidate
79 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET, DELAYED RELEASE / ORAL349 mgExact identifier — unii candidate
35 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TLOTION / TOPICAL351 mgExact identifier — unii candidate
79 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHSOLUTION / NASAL140 mgExact identifier — unii candidate
68 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3AEROSOL, FOAM / RECTAL1214 mgExact identifier — unii candidate
81 equally ranked IID candidates
FERRIC OXIDE YELLOWFERRIC OXIDE YELLOWEX438O2MRTSUSPENSION / ORAL6 mgExact identifier — unii candidate
20 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHPOWDER / ORALNAExact identifier — unii candidate
68 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3OINTMENT / TOPICAL5148 mgExact identifier — unii candidate
81 equally ranked IID candidates
TALCTALC7SEV7J4R1UCAPSULE, EXTENDED RELEASE / ORAL5119 mgExact identifier — unii candidate
35 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4TABLET / ORAL750 mgExact identifier — unii candidate
49 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHINJECTION / INTRAVENOUS6 mgExact identifier — unii candidate
68 equally ranked IID candidates
CARBOMER HOMOPOLYMER TYPE CCARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED)4Q93RCW27EGEL, METERED / TRANSDERMAL50 mgExact identifier — unii candidate
9 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4TABLET, FILM COATED / ORAL166 mgExact identifier — unii candidate
49 equally ranked IID candidates
FERRIC OXIDE YELLOWFERRIC OXIDE YELLOWEX438O2MRTCAPSULE, EXTENDED RELEASE / ORAL7 mgExact identifier — unii candidate
20 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXOINTMENT / TOPICALNAExact identifier — unii candidate
75 equally ranked IID candidates
FERRIC OXIDE REDFERRIC OXIDE RED1K09F3G675TABLET / ORAL8 mgExact identifier — unii candidate
21 equally ranked IID candidates
BUTYLPARABENBUTYLPARABEN3QPI1U3FV8CREAM / TOPICAL0.4 %w/wExact identifier — unii candidate
15 equally ranked IID candidates
BUTYLPARABENBUTYLPARABEN3QPI1U3FV8SOLUTION / RECTAL0.01 %w/vExact identifier — unii candidate
15 equally ranked IID candidates
EDETATE SODIUMEDETATE SODIUMMP1J8420LUSOLUTION / OPHTHALMIC0.1 %w/vExact identifier — unii candidate
12 equally ranked IID candidates
TALCTALC7SEV7J4R1UPOWDER, FOR SUSPENSION / ORAL735 mgExact identifier — unii candidate
35 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET / RECTAL32.4 mgExact identifier — unii candidate
35 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXEMULSION / OPHTHALMIC3 mgExact identifier — unii candidate
75 equally ranked IID candidates
SILICON DIOXIDESILICON DIOXIDEETJ7Z6XBU4CAPSULE, EXTENDED RELEASE / ORAL168 mgExact identifier — unii candidate
49 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXINJECTION / INTRADERMAL1.6 %w/vExact identifier — unii candidate
75 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
581733b5-767d-4adf-9baf-e4e3b2a58d68f6747fcd-699c-49d3-9f8d-953e7e0fd97e2010-06-04WarningsExact identifier
spl id: 581733b5-767d-4adf-9baf-e4e3b2a58d68
spl set id: f6747fcd-699c-49d3-9f8d-953e7e0fd97e

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.